Nancy A Simonian is of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 135,658 shares of SYRS, which is worth approximately $668,793. The most recent transaction as insider was on Jun 05, 2024, when has been sold 4,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 136K
3.04% 3M change
84.77% 12M change
Total Value Held $668,793

Nancy A Simonian Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
BUY
Grant, award, or other acquisition
-
4,000 Added 2.86%
135,658 Common Stock
Apr 01 2024
SELL
Payment of exercise price or tax liability
$71,946 $5.12 p/Share
14,052 Reduced 9.64%
131,658 Common Stock
Mar 31 2024
BUY
Exercise of conversion of derivative security
-
45,566 Added 23.82%
145,710 Common Stock
Nov 01 2023
SELL
Payment of exercise price or tax liability
$29,750 $2.22 p/Share
13,401 Reduced 11.8%
100,144 Common Stock
Oct 31 2023
BUY
Exercise of conversion of derivative security
-
40,125 Added 26.11%
113,545 Common Stock
Apr 03 2023
SELL
Payment of exercise price or tax liability
$4,778 $2.58 p/Share
1,852 Reduced 2.46%
73,420 Common Stock
Mar 31 2023
BUY
Exercise of conversion of derivative security
-
6,000 Added 7.38%
75,272 Common Stock
Apr 01 2022
SELL
Payment of exercise price or tax liability
$65,949 $1.12 p/Share
58,883 Reduced 7.83%
692,723 Common Stock
Dec 18 2020
BUY
Exercise of conversion of derivative security
$215,702 $7.21 p/Share
29,917 Added 5.04%
563,606 Common Stock

Also insider at

SGEN
Seagen Inc. Healthcare
NAS

Nancy A Simonian

Bothell, WA

Track Institutional and Insider Activities on SYRS

Follow Syros Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYRS shares.

Notify only if

Insider Trading

Get notified when an Syros Pharmaceuticals, Inc. insider buys or sells SYRS shares.

Notify only if

News

Receive news related to Syros Pharmaceuticals, Inc.

Track Activities on SYRS